Teresita Bellido
Concepts (477)
Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Osteocytes | 62 | 2023 | 227 | 12.910 |
Why?
| Bone and Bones | 43 | 2023 | 525 | 7.440 |
Why?
| Osteoblasts | 53 | 2022 | 531 | 5.420 |
Why?
| Osteogenesis | 31 | 2022 | 385 | 4.800 |
Why?
| Bone Resorption | 27 | 2023 | 336 | 4.800 |
Why?
| Signal Transduction | 39 | 2022 | 1733 | 4.280 |
Why?
| Parathyroid Hormone | 16 | 2024 | 200 | 4.220 |
Why?
| Bone Remodeling | 21 | 2022 | 177 | 4.010 |
Why?
| Osteoclasts | 34 | 2023 | 475 | 3.930 |
Why?
| Apoptosis | 35 | 2017 | 1299 | 3.400 |
Why?
| Glucocorticoids | 12 | 2019 | 242 | 3.100 |
Why?
| Receptor, Parathyroid Hormone, Type 1 | 9 | 2022 | 24 | 2.970 |
Why?
| Osteoporosis | 11 | 2024 | 175 | 2.400 |
Why?
| Mice | 90 | 2024 | 6464 | 2.400 |
Why?
| Animals | 118 | 2024 | 14777 | 2.350 |
Why?
| Diphosphonates | 10 | 2024 | 97 | 2.340 |
Why?
| Receptors, Notch | 5 | 2022 | 28 | 2.230 |
Why?
| Connexin 43 | 14 | 2017 | 25 | 2.210 |
Why?
| Bone Morphogenetic Proteins | 10 | 2020 | 64 | 2.100 |
Why?
| RANK Ligand | 10 | 2018 | 187 | 2.020 |
Why?
| Glycoproteins | 15 | 2019 | 129 | 1.980 |
Why?
| Mechanotransduction, Cellular | 10 | 2016 | 37 | 1.890 |
Why?
| Wnt Signaling Pathway | 10 | 2022 | 95 | 1.880 |
Why?
| Antioxidants | 4 | 2020 | 288 | 1.630 |
Why?
| beta Catenin | 8 | 2022 | 101 | 1.570 |
Why?
| Adaptor Proteins, Signal Transducing | 19 | 2020 | 205 | 1.470 |
Why?
| Bone Density Conservation Agents | 7 | 2024 | 84 | 1.470 |
Why?
| Extracellular Signal-Regulated MAP Kinases | 10 | 2013 | 100 | 1.330 |
Why?
| Bone Density | 22 | 2024 | 438 | 1.320 |
Why?
| Intercellular Signaling Peptides and Proteins | 16 | 2019 | 119 | 1.190 |
Why?
| Osteoporosis, Postmenopausal | 4 | 2024 | 39 | 1.160 |
Why?
| Mice, Knockout | 18 | 2022 | 938 | 1.130 |
Why?
| Cells, Cultured | 30 | 2018 | 1731 | 1.120 |
Why?
| NF-E2-Related Factor 2 | 2 | 2017 | 62 | 1.100 |
Why?
| Teriparatide | 3 | 2024 | 14 | 1.100 |
Why?
| Mice, Inbred C57BL | 21 | 2022 | 2013 | 1.090 |
Why?
| Focal Adhesion Kinase 2 | 3 | 2019 | 13 | 1.090 |
Why?
| Diabetes Mellitus, Type 1 | 3 | 2024 | 202 | 1.090 |
Why?
| Anoikis | 2 | 2019 | 9 | 1.000 |
Why?
| Receptors, Parathyroid Hormone | 3 | 2014 | 12 | 0.930 |
Why?
| Mice, Transgenic | 11 | 2015 | 639 | 0.810 |
Why?
| Parathyroid Hormone-Related Protein | 2 | 2024 | 26 | 0.800 |
Why?
| Cell Differentiation | 11 | 2021 | 721 | 0.800 |
Why?
| Aging | 6 | 2018 | 794 | 0.800 |
Why?
| Bone Marrow | 6 | 2016 | 396 | 0.750 |
Why?
| Fractures, Bone | 3 | 2023 | 120 | 0.750 |
Why?
| Calcitriol | 10 | 2005 | 41 | 0.740 |
Why?
| Cell Survival | 13 | 2019 | 676 | 0.740 |
Why?
| Weight-Bearing | 6 | 2016 | 58 | 0.730 |
Why?
| Diabetes Mellitus, Experimental | 2 | 2023 | 138 | 0.720 |
Why?
| Cell Communication | 3 | 2022 | 70 | 0.710 |
Why?
| Alendronate | 8 | 2015 | 27 | 0.700 |
Why?
| Wnt Proteins | 7 | 2013 | 110 | 0.700 |
Why?
| Female | 42 | 2024 | 28520 | 0.690 |
Why?
| Mitogen-Activated Protein Kinases | 5 | 2004 | 176 | 0.670 |
Why?
| Gap Junctions | 3 | 2017 | 29 | 0.660 |
Why?
| Stress, Mechanical | 5 | 2013 | 97 | 0.660 |
Why?
| Matrix Metalloproteinase 14 | 1 | 2018 | 5 | 0.630 |
Why?
| Humans | 63 | 2024 | 54581 | 0.620 |
Why?
| Interleukin-6 | 10 | 1998 | 317 | 0.610 |
Why?
| Bone Marrow Cells | 9 | 2021 | 229 | 0.590 |
Why?
| Adipogenesis | 1 | 2017 | 54 | 0.580 |
Why?
| Collagen Type I | 4 | 2015 | 98 | 0.580 |
Why?
| ortho-Aminobenzoates | 1 | 2016 | 9 | 0.570 |
Why?
| Ubiquitin-Protein Ligases | 1 | 2017 | 100 | 0.560 |
Why?
| Muscular Atrophy | 1 | 2017 | 73 | 0.560 |
Why?
| Fracture Healing | 1 | 2016 | 28 | 0.560 |
Why?
| Fibroblast Growth Factors | 3 | 2017 | 54 | 0.550 |
Why?
| Down-Regulation | 7 | 2017 | 383 | 0.550 |
Why?
| Adipocytes | 1 | 2017 | 128 | 0.550 |
Why?
| Organ Size | 7 | 2019 | 247 | 0.540 |
Why?
| Cellular Microenvironment | 1 | 2016 | 27 | 0.540 |
Why?
| Peptides | 4 | 2015 | 275 | 0.530 |
Why?
| Caveolin 1 | 2 | 2013 | 22 | 0.520 |
Why?
| Estrogen Receptor beta | 3 | 2022 | 56 | 0.520 |
Why?
| src-Family Kinases | 4 | 2005 | 58 | 0.510 |
Why?
| Models, Biological | 10 | 2016 | 809 | 0.510 |
Why?
| Extracellular Matrix Proteins | 6 | 2022 | 76 | 0.510 |
Why?
| MAP Kinase Signaling System | 4 | 2012 | 131 | 0.490 |
Why?
| Periosteum | 2 | 2012 | 29 | 0.490 |
Why?
| Genetic Markers | 8 | 2020 | 117 | 0.490 |
Why?
| Low Density Lipoprotein Receptor-Related Protein-5 | 4 | 2023 | 7 | 0.480 |
Why?
| Endoplasmic Reticulum | 1 | 2014 | 106 | 0.470 |
Why?
| Gene Deletion | 7 | 2019 | 285 | 0.470 |
Why?
| Hematopoietic Stem Cells | 2 | 2012 | 206 | 0.460 |
Why?
| Estrogens | 6 | 2007 | 249 | 0.460 |
Why?
| Phosphorylation | 12 | 2014 | 602 | 0.440 |
Why?
| Multiple Myeloma | 5 | 2022 | 2967 | 0.430 |
Why?
| Cell Line | 16 | 2014 | 1139 | 0.430 |
Why?
| Muscles | 5 | 1993 | 118 | 0.430 |
Why?
| Phosphates | 5 | 2016 | 52 | 0.430 |
Why?
| RNA, Messenger | 8 | 2017 | 1231 | 0.410 |
Why?
| Up-Regulation | 7 | 2014 | 499 | 0.410 |
Why?
| Hyperostosis | 2 | 2022 | 4 | 0.400 |
Why?
| Enzyme Inhibitors | 6 | 2014 | 448 | 0.400 |
Why?
| Phosphoproteins | 3 | 2018 | 110 | 0.390 |
Why?
| Gene Expression Regulation | 8 | 2017 | 1075 | 0.370 |
Why?
| Gene Expression | 5 | 2017 | 662 | 0.370 |
Why?
| Enzyme Activation | 9 | 2010 | 329 | 0.370 |
Why?
| Estrogen Receptor alpha | 3 | 2022 | 95 | 0.350 |
Why?
| Male | 25 | 2024 | 27656 | 0.350 |
Why?
| Receptors, Estrogen | 7 | 2022 | 140 | 0.350 |
Why?
| Focal Adhesion Kinase 1 | 2 | 2007 | 15 | 0.350 |
Why?
| X-Ray Microtomography | 6 | 2022 | 80 | 0.340 |
Why?
| MicroRNAs | 3 | 2019 | 381 | 0.330 |
Why?
| Cytokines | 7 | 2014 | 691 | 0.330 |
Why?
| Cell Membrane | 2 | 2007 | 279 | 0.320 |
Why?
| Monocytes | 1 | 2008 | 156 | 0.290 |
Why?
| Osteolysis | 3 | 2022 | 83 | 0.280 |
Why?
| Weightlessness | 1 | 2006 | 16 | 0.280 |
Why?
| Membrane Glycoproteins | 5 | 2003 | 270 | 0.280 |
Why?
| Osteoprotegerin | 2 | 2016 | 56 | 0.280 |
Why?
| Protein-Tyrosine Kinases | 3 | 2010 | 100 | 0.280 |
Why?
| Dexamethasone | 7 | 2017 | 434 | 0.270 |
Why?
| HeLa Cells | 10 | 2017 | 278 | 0.270 |
Why?
| Calcifediol | 4 | 1991 | 9 | 0.270 |
Why?
| Transcription Factors | 3 | 2004 | 631 | 0.260 |
Why?
| Integrins | 1 | 2005 | 34 | 0.260 |
Why?
| Cell Nucleus | 5 | 2013 | 211 | 0.260 |
Why?
| Caspases | 3 | 2006 | 146 | 0.260 |
Why?
| Skull | 5 | 2015 | 78 | 0.250 |
Why?
| Hormone Replacement Therapy | 1 | 2004 | 28 | 0.250 |
Why?
| Caspase 3 | 5 | 2017 | 130 | 0.240 |
Why?
| Estradiol | 9 | 2007 | 239 | 0.240 |
Why?
| Multienzyme Complexes | 1 | 2003 | 41 | 0.230 |
Why?
| Antigens, CD | 4 | 2000 | 237 | 0.230 |
Why?
| Cysteine Endopeptidases | 1 | 2003 | 76 | 0.230 |
Why?
| Calcium Channels | 2 | 2001 | 58 | 0.230 |
Why?
| Gingivitis | 1 | 2023 | 2 | 0.220 |
Why?
| Rats | 9 | 2014 | 3660 | 0.220 |
Why?
| Alveolar Bone Loss | 1 | 2023 | 14 | 0.220 |
Why?
| Actins | 2 | 2005 | 135 | 0.220 |
Why?
| Periodontitis | 1 | 2023 | 9 | 0.220 |
Why?
| Kinetics | 8 | 2004 | 705 | 0.220 |
Why?
| Protein Kinases | 2 | 2014 | 81 | 0.220 |
Why?
| Bone Diseases, Metabolic | 1 | 2023 | 85 | 0.220 |
Why?
| Tumor Necrosis Factor-alpha | 5 | 2016 | 450 | 0.210 |
Why?
| Tuberous Sclerosis | 1 | 2022 | 39 | 0.210 |
Why?
| Absorptiometry, Photon | 3 | 2023 | 172 | 0.210 |
Why?
| Phosphotyrosine | 2 | 1999 | 7 | 0.210 |
Why?
| Transfection | 6 | 2007 | 393 | 0.210 |
Why?
| Tumor Suppressor Proteins | 1 | 2022 | 142 | 0.200 |
Why?
| Dihydrotestosterone | 4 | 2006 | 17 | 0.200 |
Why?
| Transcription, Genetic | 8 | 2006 | 431 | 0.200 |
Why?
| Disease Models, Animal | 6 | 2021 | 1653 | 0.200 |
Why?
| Bone Matrix | 2 | 2019 | 20 | 0.200 |
Why?
| Receptors, Androgen | 3 | 2006 | 50 | 0.190 |
Why?
| Neoplasm Proteins | 1 | 2003 | 347 | 0.190 |
Why?
| Cell Division | 6 | 2005 | 341 | 0.190 |
Why?
| Calcium | 5 | 2023 | 440 | 0.190 |
Why?
| Ovariectomy | 5 | 2014 | 136 | 0.190 |
Why?
| Trans-Activators | 3 | 2018 | 148 | 0.190 |
Why?
| Mutation | 5 | 2023 | 1420 | 0.190 |
Why?
| Phenotype | 3 | 2020 | 798 | 0.180 |
Why?
| Dentin | 1 | 2019 | 6 | 0.180 |
Why?
| Sex Characteristics | 2 | 2023 | 212 | 0.180 |
Why?
| Phylogeny | 1 | 2020 | 268 | 0.180 |
Why?
| Calcitonin | 1 | 1999 | 38 | 0.180 |
Why?
| Lymphokines | 2 | 1997 | 22 | 0.170 |
Why?
| DNA-Binding Proteins | 3 | 2003 | 474 | 0.170 |
Why?
| Cell Proliferation | 2 | 2016 | 1075 | 0.170 |
Why?
| Dose-Response Relationship, Drug | 4 | 2021 | 1529 | 0.170 |
Why?
| Growth Inhibitors | 2 | 1997 | 30 | 0.170 |
Why?
| Protein Binding | 4 | 2011 | 710 | 0.170 |
Why?
| Receptors, Interleukin-17 | 1 | 2018 | 2 | 0.170 |
Why?
| Dental Cementum | 1 | 2018 | 1 | 0.170 |
Why?
| Tooth Ankylosis | 1 | 2018 | 1 | 0.170 |
Why?
| Gonadal Steroid Hormones | 3 | 2007 | 45 | 0.170 |
Why?
| Anabolic Agents | 1 | 2019 | 33 | 0.170 |
Why?
| Bone Diseases | 2 | 2017 | 101 | 0.170 |
Why?
| Tretinoin | 1 | 1999 | 58 | 0.160 |
Why?
| Mefloquine | 1 | 2018 | 5 | 0.160 |
Why?
| Cyclins | 1 | 1998 | 54 | 0.160 |
Why?
| Primary Cell Culture | 2 | 2017 | 64 | 0.160 |
Why?
| Reverse Transcriptase Polymerase Chain Reaction | 3 | 2019 | 664 | 0.150 |
Why?
| Chick Embryo | 6 | 2001 | 84 | 0.150 |
Why?
| Repressor Proteins | 1 | 2019 | 164 | 0.150 |
Why?
| Culture Media, Conditioned | 3 | 2023 | 52 | 0.150 |
Why?
| Femur | 2 | 2015 | 140 | 0.150 |
Why?
| Bone Development | 1 | 2018 | 72 | 0.150 |
Why?
| Oxidative Stress | 2 | 2017 | 949 | 0.150 |
Why?
| Nuclear Respiratory Factor 1 | 1 | 2017 | 2 | 0.150 |
Why?
| Basic-Leucine Zipper Transcription Factors | 1 | 2017 | 15 | 0.150 |
Why?
| Glucuronidase | 1 | 2017 | 49 | 0.150 |
Why?
| Mice, 129 Strain | 1 | 2017 | 48 | 0.150 |
Why?
| Osteoporotic Fractures | 1 | 2017 | 13 | 0.150 |
Why?
| Hyponatremia | 1 | 2017 | 15 | 0.150 |
Why?
| Gene Regulatory Networks | 1 | 2018 | 118 | 0.150 |
Why?
| Diet | 1 | 2020 | 601 | 0.140 |
Why?
| Immunohistochemistry | 3 | 2017 | 1090 | 0.140 |
Why?
| Hypophosphatemia, Familial | 1 | 2016 | 1 | 0.140 |
Why?
| Cyclin D1 | 1 | 2016 | 59 | 0.140 |
Why?
| Receptors, Interleukin | 1 | 1996 | 10 | 0.140 |
Why?
| Receptors, Nerve Growth Factor | 1 | 1996 | 8 | 0.140 |
Why?
| Receptors, Cytokine | 1 | 1996 | 12 | 0.140 |
Why?
| Random Allocation | 1 | 2017 | 317 | 0.140 |
Why?
| Integrases | 2 | 2022 | 44 | 0.140 |
Why?
| Etoposide | 4 | 2005 | 83 | 0.140 |
Why?
| Focal Adhesion Protein-Tyrosine Kinases | 2 | 2010 | 20 | 0.140 |
Why?
| JNK Mitogen-Activated Protein Kinases | 2 | 2007 | 83 | 0.140 |
Why?
| Infant, Newborn | 1 | 2024 | 2931 | 0.140 |
Why?
| Peptide Fragments | 3 | 2015 | 240 | 0.130 |
Why?
| Protein Structure, Tertiary | 4 | 2015 | 271 | 0.130 |
Why?
| Hindlimb | 1 | 2015 | 32 | 0.130 |
Why?
| Estrenes | 3 | 2006 | 16 | 0.130 |
Why?
| Core Binding Factor Alpha 1 Subunit | 2 | 2006 | 48 | 0.130 |
Why?
| Hematopoiesis | 2 | 2014 | 83 | 0.130 |
Why?
| Hindlimb Suspension | 1 | 2015 | 45 | 0.130 |
Why?
| Adiposity | 1 | 2016 | 135 | 0.130 |
Why?
| Mutation, Missense | 1 | 2015 | 108 | 0.130 |
Why?
| Time Factors | 7 | 2015 | 3223 | 0.130 |
Why?
| Homeostasis | 2 | 2012 | 227 | 0.130 |
Why?
| Osteocalcin | 3 | 2014 | 51 | 0.130 |
Why?
| Promoter Regions, Genetic | 3 | 2008 | 532 | 0.130 |
Why?
| Testosterone | 1 | 1995 | 148 | 0.120 |
Why?
| Enzyme Activators | 1 | 2014 | 8 | 0.120 |
Why?
| Receptors, Calcitriol | 3 | 2005 | 22 | 0.120 |
Why?
| Protein Kinase C | 2 | 2003 | 75 | 0.120 |
Why?
| Nucleic Acid Synthesis Inhibitors | 2 | 2005 | 17 | 0.120 |
Why?
| Phosphatidylinositol 3-Kinases | 2 | 2005 | 148 | 0.120 |
Why?
| Sirtuin 1 | 1 | 2014 | 27 | 0.120 |
Why?
| Organ Culture Techniques | 1 | 2014 | 55 | 0.120 |
Why?
| Protein Tyrosine Phosphatases | 1 | 2014 | 29 | 0.120 |
Why?
| Lymphoid Tissue | 1 | 1994 | 23 | 0.120 |
Why?
| Myeloproliferative Disorders | 1 | 2014 | 29 | 0.120 |
Why?
| LDL-Receptor Related Proteins | 2 | 2011 | 11 | 0.120 |
Why?
| Gene Expression Regulation, Developmental | 1 | 2014 | 150 | 0.120 |
Why?
| Receptors, Steroid | 1 | 1993 | 21 | 0.120 |
Why?
| Blotting, Western | 5 | 2011 | 682 | 0.110 |
Why?
| Transcriptome | 1 | 2016 | 349 | 0.110 |
Why?
| Injections, Subcutaneous | 1 | 2013 | 57 | 0.110 |
Why?
| Transforming Growth Factor beta1 | 1 | 2014 | 65 | 0.110 |
Why?
| Receptor Cross-Talk | 1 | 2013 | 7 | 0.110 |
Why?
| TCF Transcription Factors | 1 | 2013 | 11 | 0.110 |
Why?
| Hematologic Neoplasms | 1 | 2014 | 99 | 0.110 |
Why?
| Gene Knockdown Techniques | 1 | 2013 | 117 | 0.110 |
Why?
| Flavonoids | 1 | 2013 | 62 | 0.110 |
Why?
| Ulna | 2 | 2013 | 17 | 0.110 |
Why?
| Protein Transport | 1 | 2013 | 190 | 0.110 |
Why?
| RNA, Small Interfering | 1 | 2013 | 241 | 0.100 |
Why?
| Arrestins | 1 | 2011 | 1 | 0.100 |
Why?
| Flow Cytometry | 2 | 2012 | 536 | 0.100 |
Why?
| Societies, Scientific | 1 | 2011 | 14 | 0.100 |
Why?
| Immunoenzyme Techniques | 1 | 2012 | 160 | 0.100 |
Why?
| Transgenes | 1 | 2011 | 59 | 0.100 |
Why?
| Ligands | 3 | 2007 | 231 | 0.100 |
Why?
| Absorption | 1 | 2011 | 24 | 0.100 |
Why?
| Health | 1 | 2011 | 28 | 0.100 |
Why?
| Minerals | 1 | 2011 | 35 | 0.100 |
Why?
| Fluorescent Dyes | 2 | 2023 | 117 | 0.100 |
Why?
| Lumbar Vertebrae | 2 | 2018 | 105 | 0.100 |
Why?
| Proto-Oncogene Proteins c-akt | 2 | 2017 | 169 | 0.100 |
Why?
| Etidronic Acid | 2 | 2001 | 6 | 0.100 |
Why?
| Cytokine Receptor gp130 | 4 | 2000 | 13 | 0.100 |
Why?
| Muscle, Skeletal | 1 | 2017 | 827 | 0.100 |
Why?
| Fibroblasts | 3 | 2001 | 373 | 0.090 |
Why?
| Estrogen Antagonists | 2 | 2007 | 20 | 0.090 |
Why?
| Extracellular Matrix | 1 | 2010 | 118 | 0.090 |
Why?
| Spine | 1 | 2010 | 112 | 0.090 |
Why?
| Hormones | 2 | 2008 | 62 | 0.080 |
Why?
| Dactinomycin | 2 | 2003 | 24 | 0.080 |
Why?
| Green Fluorescent Proteins | 3 | 2005 | 106 | 0.080 |
Why?
| Gene Silencing | 1 | 2008 | 126 | 0.080 |
Why?
| Molecular Structure | 2 | 2006 | 320 | 0.080 |
Why?
| Nifedipine | 2 | 2001 | 24 | 0.080 |
Why?
| Biomedical Research | 1 | 2011 | 249 | 0.080 |
Why?
| Base Sequence | 4 | 1998 | 716 | 0.080 |
Why?
| Stem Cells | 2 | 2006 | 193 | 0.080 |
Why?
| Phospholipids | 1 | 1987 | 67 | 0.080 |
Why?
| Cattle | 1 | 2008 | 229 | 0.070 |
Why?
| Dihydroxycholecalciferols | 1 | 1987 | 3 | 0.070 |
Why?
| Tibia | 1 | 2007 | 124 | 0.070 |
Why?
| bcl-Associated Death Protein | 2 | 2003 | 13 | 0.070 |
Why?
| Fatty Acids | 1 | 1987 | 156 | 0.070 |
Why?
| Leukemia Inhibitory Factor | 2 | 1997 | 15 | 0.070 |
Why?
| Genotype | 1 | 2008 | 612 | 0.070 |
Why?
| Membrane Proteins | 1 | 1989 | 379 | 0.070 |
Why?
| Weight Gain | 1 | 2008 | 253 | 0.070 |
Why?
| Cyclic AMP-Dependent Protein Kinases | 2 | 2004 | 57 | 0.070 |
Why?
| Spleen | 1 | 2008 | 194 | 0.070 |
Why?
| Disease Progression | 2 | 2021 | 882 | 0.070 |
Why?
| Cell Count | 1 | 2006 | 182 | 0.070 |
Why?
| RNA | 2 | 2005 | 191 | 0.070 |
Why?
| Kidney | 1 | 2011 | 838 | 0.070 |
Why?
| Injections | 1 | 2005 | 62 | 0.070 |
Why?
| Caveolae | 1 | 2005 | 7 | 0.070 |
Why?
| Physical Stimulation | 1 | 2005 | 38 | 0.070 |
Why?
| beta-Cyclodextrins | 1 | 2005 | 19 | 0.070 |
Why?
| Tubulin | 1 | 2005 | 27 | 0.060 |
Why?
| src Homology Domains | 2 | 2001 | 9 | 0.060 |
Why?
| Cytoskeleton | 1 | 2005 | 47 | 0.060 |
Why?
| Mitogen-Activated Protein Kinase Kinases | 1 | 2005 | 39 | 0.060 |
Why?
| Ribosomal Protein S6 Kinases, 90-kDa | 1 | 2004 | 7 | 0.060 |
Why?
| Cycloheximide | 3 | 2005 | 39 | 0.060 |
Why?
| Cell Line, Tumor | 2 | 2021 | 1503 | 0.060 |
Why?
| Carrier Proteins | 2 | 2003 | 367 | 0.060 |
Why?
| Drug Administration Schedule | 1 | 2005 | 405 | 0.060 |
Why?
| Drug Synergism | 1 | 2004 | 168 | 0.060 |
Why?
| Binding Sites | 3 | 2012 | 429 | 0.060 |
Why?
| Receptors, Interleukin-6 | 3 | 2000 | 26 | 0.060 |
Why?
| Gene Expression Regulation, Enzymologic | 1 | 2005 | 201 | 0.060 |
Why?
| Receptor Activator of Nuclear Factor-kappa B | 1 | 2003 | 34 | 0.060 |
Why?
| Cyclic AMP Response Element-Binding Protein | 1 | 2003 | 39 | 0.060 |
Why?
| Carcinogens | 1 | 2005 | 246 | 0.060 |
Why?
| CD40 Ligand | 1 | 2003 | 15 | 0.060 |
Why?
| Calcium-Calmodulin-Dependent Protein Kinase Kinase | 1 | 2023 | 1 | 0.060 |
Why?
| Prednisolone | 2 | 2002 | 64 | 0.060 |
Why?
| Alveolar Process | 1 | 2023 | 14 | 0.060 |
Why?
| NF-kappa B | 2 | 2014 | 340 | 0.060 |
Why?
| DNA | 3 | 2005 | 597 | 0.060 |
Why?
| Models, Genetic | 1 | 2003 | 205 | 0.050 |
Why?
| Proteasome Endopeptidase Complex | 1 | 2003 | 133 | 0.050 |
Why?
| Proto-Oncogene Proteins c-bcl-2 | 1 | 2003 | 156 | 0.050 |
Why?
| Homeodomain Proteins | 1 | 2022 | 85 | 0.050 |
Why?
| Tumor Cells, Cultured | 2 | 2002 | 508 | 0.050 |
Why?
| Embryo, Mammalian | 1 | 2001 | 72 | 0.050 |
Why?
| Luminescent Proteins | 1 | 2001 | 65 | 0.050 |
Why?
| Clodronic Acid | 1 | 2021 | 19 | 0.050 |
Why?
| Calcium Channel Blockers | 1 | 2001 | 71 | 0.050 |
Why?
| STAT3 Transcription Factor | 2 | 2000 | 86 | 0.050 |
Why?
| Biotinylation | 1 | 2001 | 26 | 0.050 |
Why?
| Models, Animal | 2 | 2013 | 268 | 0.050 |
Why?
| Isoquinolines | 1 | 2001 | 29 | 0.050 |
Why?
| Body Weight | 2 | 2019 | 584 | 0.050 |
Why?
| Interleukin-5 | 1 | 2000 | 6 | 0.050 |
Why?
| Xenograft Model Antitumor Assays | 1 | 2021 | 220 | 0.050 |
Why?
| Cell-Free System | 1 | 2000 | 16 | 0.050 |
Why?
| Orchiectomy | 2 | 2002 | 48 | 0.050 |
Why?
| Odontogenesis | 1 | 2019 | 1 | 0.040 |
Why?
| Dental Pulp | 1 | 2019 | 2 | 0.040 |
Why?
| Recombinant Proteins | 2 | 1998 | 540 | 0.040 |
Why?
| Odontoblasts | 1 | 2019 | 5 | 0.040 |
Why?
| In Situ Nick-End Labeling | 1 | 1999 | 64 | 0.040 |
Why?
| Semaphorins | 1 | 2019 | 4 | 0.040 |
Why?
| Rifabutin | 1 | 1999 | 5 | 0.040 |
Why?
| Lactams, Macrocyclic | 1 | 1999 | 14 | 0.040 |
Why?
| Isotretinoin | 1 | 1999 | 8 | 0.040 |
Why?
| Quinones | 1 | 1999 | 10 | 0.040 |
Why?
| Benzoquinones | 1 | 1999 | 33 | 0.040 |
Why?
| Periodontal Ligament | 1 | 2018 | 2 | 0.040 |
Why?
| Tooth Eruption | 1 | 2018 | 2 | 0.040 |
Why?
| Transcription Factor AP-1 | 1 | 2019 | 71 | 0.040 |
Why?
| Mice, Mutant Strains | 2 | 2015 | 82 | 0.040 |
Why?
| Sodium | 2 | 1991 | 109 | 0.040 |
Why?
| Biological Transport | 2 | 1991 | 190 | 0.040 |
Why?
| Cell Adhesion Molecules | 1 | 1999 | 87 | 0.040 |
Why?
| Interleukin-17 | 1 | 2018 | 37 | 0.040 |
Why?
| Oligonucleotides, Antisense | 1 | 1998 | 31 | 0.040 |
Why?
| Cytoplasm | 3 | 2004 | 105 | 0.040 |
Why?
| Growth Substances | 1 | 1998 | 29 | 0.040 |
Why?
| Cyclin-Dependent Kinase Inhibitor p21 | 1 | 1998 | 95 | 0.040 |
Why?
| Inflammation | 1 | 2023 | 679 | 0.040 |
Why?
| Hyperparathyroidism, Primary | 1 | 2018 | 51 | 0.040 |
Why?
| Connective Tissue Cells | 1 | 1997 | 1 | 0.040 |
Why?
| Molecular Sequence Data | 3 | 1995 | 956 | 0.040 |
Why?
| Ciliary Neurotrophic Factor | 1 | 1997 | 11 | 0.040 |
Why?
| Calcium-Calmodulin-Dependent Protein Kinases | 1 | 1997 | 36 | 0.040 |
Why?
| Osteogenesis Imperfecta | 1 | 2018 | 38 | 0.040 |
Why?
| STAT1 Transcription Factor | 1 | 1997 | 26 | 0.040 |
Why?
| Endometrial Neoplasms | 1 | 1999 | 140 | 0.040 |
Why?
| Analysis of Variance | 1 | 1999 | 639 | 0.040 |
Why?
| HMGB1 Protein | 1 | 2017 | 17 | 0.040 |
Why?
| Genetic Complementation Test | 1 | 2017 | 51 | 0.040 |
Why?
| Proto-Oncogene Proteins | 3 | 2005 | 167 | 0.040 |
Why?
| Alkaline Phosphatase | 1 | 1997 | 99 | 0.040 |
Why?
| PTEN Phosphohydrolase | 1 | 2017 | 59 | 0.040 |
Why?
| Lymphocyte Activation | 2 | 1995 | 194 | 0.040 |
Why?
| Tetradecanoylphorbol Acetate | 2 | 1994 | 50 | 0.040 |
Why?
| Tumor Suppressor Protein p53 | 1 | 1998 | 249 | 0.040 |
Why?
| Cell Cycle Proteins | 1 | 2018 | 193 | 0.040 |
Why?
| Receptor, Ciliary Neurotrophic Factor | 1 | 1996 | 1 | 0.030 |
Why?
| Receptors, Interleukin-11 | 1 | 1996 | 1 | 0.030 |
Why?
| Interleukin-11 Receptor alpha Subunit | 1 | 1996 | 1 | 0.030 |
Why?
| Receptors, OSM-LIF | 1 | 1996 | 2 | 0.030 |
Why?
| Receptors, Oncostatin M | 1 | 1996 | 2 | 0.030 |
Why?
| Leukemia Inhibitory Factor Receptor alpha Subunit | 1 | 1996 | 2 | 0.030 |
Why?
| Biological Assay | 1 | 1996 | 50 | 0.030 |
Why?
| Gene Knock-In Techniques | 1 | 2015 | 30 | 0.030 |
Why?
| Gait | 1 | 2017 | 103 | 0.030 |
Why?
| Nerve Tissue Proteins | 1 | 1997 | 203 | 0.030 |
Why?
| Amino Acid Substitution | 1 | 2015 | 99 | 0.030 |
Why?
| Genetic Loci | 1 | 2015 | 53 | 0.030 |
Why?
| Accidental Falls | 1 | 2017 | 103 | 0.030 |
Why?
| X-Rays | 1 | 2015 | 61 | 0.030 |
Why?
| Dose-Response Relationship, Radiation | 1 | 2015 | 209 | 0.030 |
Why?
| Epigenetic Repression | 1 | 2014 | 1 | 0.030 |
Why?
| Lymphocytes | 1 | 1995 | 171 | 0.030 |
Why?
| Immunoglobulin J Recombination Signal Sequence-Binding Protein | 1 | 2014 | 2 | 0.030 |
Why?
| Adenocarcinoma | 1 | 1999 | 425 | 0.030 |
Why?
| Stem Cell Niche | 1 | 2014 | 10 | 0.030 |
Why?
| Steroids | 1 | 1995 | 59 | 0.030 |
Why?
| Androgens | 2 | 2007 | 75 | 0.030 |
Why?
| Antigens, Differentiation | 1 | 2014 | 22 | 0.030 |
Why?
| Adjuvants, Immunologic | 1 | 1994 | 62 | 0.030 |
Why?
| Inflammation Mediators | 1 | 2014 | 126 | 0.030 |
Why?
| Antibodies, Neutralizing | 1 | 2014 | 74 | 0.030 |
Why?
| Plasmids | 2 | 2004 | 182 | 0.030 |
Why?
| Bucladesine | 1 | 1993 | 5 | 0.030 |
Why?
| 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester | 1 | 1993 | 10 | 0.030 |
Why?
| Staurosporine | 1 | 1993 | 13 | 0.030 |
Why?
| Diglycerides | 1 | 1993 | 12 | 0.030 |
Why?
| Algorithms | 1 | 2017 | 686 | 0.030 |
Why?
| Body Composition | 1 | 2015 | 351 | 0.030 |
Why?
| Alkaloids | 1 | 1993 | 37 | 0.030 |
Why?
| Antibodies, Monoclonal | 1 | 2017 | 559 | 0.030 |
Why?
| Transforming Growth Factor beta | 2 | 2006 | 162 | 0.030 |
Why?
| Haversian System | 1 | 2012 | 1 | 0.030 |
Why?
| Vanadates | 1 | 2012 | 14 | 0.030 |
Why?
| Binding, Competitive | 1 | 2012 | 114 | 0.030 |
Why?
| Heart | 1 | 1994 | 350 | 0.030 |
Why?
| Polymerase Chain Reaction | 1 | 1993 | 534 | 0.030 |
Why?
| Risk Assessment | 1 | 2017 | 1360 | 0.030 |
Why?
| Tissue Distribution | 1 | 2012 | 181 | 0.030 |
Why?
| Immunoprecipitation | 1 | 2011 | 68 | 0.030 |
Why?
| Ion Channels | 1 | 2012 | 77 | 0.020 |
Why?
| Spectrometry, X-Ray Emission | 1 | 2011 | 9 | 0.020 |
Why?
| Microscopy, Confocal | 1 | 2011 | 108 | 0.020 |
Why?
| Phosphorus Radioisotopes | 1 | 1991 | 20 | 0.020 |
Why?
| Cholecalciferol | 1 | 1991 | 25 | 0.020 |
Why?
| Rats, Long-Evans | 1 | 2011 | 29 | 0.020 |
Why?
| Rabbits | 1 | 2012 | 425 | 0.020 |
Why?
| Real-Time Polymerase Chain Reaction | 1 | 2011 | 203 | 0.020 |
Why?
| Microscopy, Electron | 1 | 2011 | 94 | 0.020 |
Why?
| Spectrum Analysis, Raman | 1 | 2011 | 67 | 0.020 |
Why?
| Cell Culture Techniques | 1 | 2011 | 110 | 0.020 |
Why?
| Gene Expression Regulation, Neoplastic | 1 | 2014 | 852 | 0.020 |
Why?
| Motor Activity | 1 | 2011 | 265 | 0.020 |
Why?
| Rats, Sprague-Dawley | 1 | 2014 | 1784 | 0.020 |
Why?
| Physical Exertion | 1 | 2009 | 71 | 0.020 |
Why?
| Leucine | 1 | 1989 | 118 | 0.020 |
Why?
| Antineoplastic Agents | 1 | 2017 | 1299 | 0.020 |
Why?
| Genetic Predisposition to Disease | 1 | 2011 | 560 | 0.020 |
Why?
| In Situ Hybridization | 1 | 2007 | 84 | 0.020 |
Why?
| Rats, Inbred Lew | 1 | 2007 | 73 | 0.020 |
Why?
| Risk Factors | 1 | 2017 | 3915 | 0.020 |
Why?
| Weightlessness Simulation | 1 | 2007 | 24 | 0.020 |
Why?
| 24,25-Dihydroxyvitamin D 3 | 1 | 1987 | 3 | 0.020 |
Why?
| Smad Proteins | 1 | 2006 | 12 | 0.020 |
Why?
| Response Elements | 1 | 2006 | 32 | 0.020 |
Why?
| Bone Morphogenetic Protein 2 | 1 | 2006 | 52 | 0.020 |
Why?
| Chickens | 1 | 1987 | 114 | 0.020 |
Why?
| Vitamin D Deficiency | 1 | 1987 | 53 | 0.020 |
Why?
| Wnt3 Protein | 1 | 2005 | 7 | 0.020 |
Why?
| Wnt1 Protein | 1 | 2005 | 10 | 0.020 |
Why?
| Culture Media, Serum-Free | 1 | 2005 | 19 | 0.020 |
Why?
| Wnt3A Protein | 1 | 2005 | 12 | 0.020 |
Why?
| Culture Media | 1 | 2005 | 105 | 0.020 |
Why?
| Cholera Toxin | 1 | 2004 | 16 | 0.020 |
Why?
| MAP Kinase Kinase 4 | 1 | 2005 | 34 | 0.020 |
Why?
| Active Transport, Cell Nucleus | 1 | 2004 | 44 | 0.020 |
Why?
| Mitogen-Activated Protein Kinase 1 | 1 | 2004 | 57 | 0.020 |
Why?
| Fatty Acids, Unsaturated | 1 | 2004 | 48 | 0.020 |
Why?
| 11-beta-Hydroxysteroid Dehydrogenase Type 2 | 1 | 2003 | 12 | 0.010 |
Why?
| Caspase Inhibitors | 1 | 2003 | 30 | 0.010 |
Why?
| Tensile Strength | 1 | 2003 | 33 | 0.010 |
Why?
| CCAAT-Enhancer-Binding Protein-alpha | 1 | 2003 | 5 | 0.010 |
Why?
| ets-Domain Protein Elk-1 | 1 | 2003 | 6 | 0.010 |
Why?
| Phosphotransferases | 1 | 2003 | 19 | 0.010 |
Why?
| Selective Estrogen Receptor Modulators | 1 | 2003 | 25 | 0.010 |
Why?
| Proto-Oncogene Proteins c-fos | 1 | 2003 | 69 | 0.010 |
Why?
| Genes, Reporter | 1 | 2003 | 100 | 0.010 |
Why?
| Proto-Oncogene Proteins c-jun | 1 | 2003 | 82 | 0.010 |
Why?
| Compressive Strength | 1 | 2002 | 16 | 0.010 |
Why?
| Seminal Vesicles | 1 | 2002 | 16 | 0.010 |
Why?
| Uterus | 1 | 2002 | 99 | 0.010 |
Why?
| Pyrazoles | 1 | 2002 | 117 | 0.010 |
Why?
| Oncostatin M | 1 | 2000 | 5 | 0.010 |
Why?
| 3T3 Cells | 1 | 2000 | 58 | 0.010 |
Why?
| Transcriptional Activation | 1 | 2001 | 134 | 0.010 |
Why?
| Sex Factors | 1 | 2001 | 772 | 0.010 |
Why?
| Stromal Cells | 1 | 1997 | 78 | 0.010 |
Why?
| Proto-Oncogene Proteins c-rel | 1 | 1995 | 5 | 0.010 |
Why?
| Oligodeoxyribonucleotides | 1 | 1995 | 33 | 0.010 |
Why?
| Chloramphenicol O-Acetyltransferase | 1 | 1994 | 9 | 0.010 |
Why?
| Breast Neoplasms | 1 | 2002 | 1252 | 0.010 |
Why?
| Myocardium | 1 | 1994 | 450 | 0.010 |
Why?
| Adult | 1 | 1995 | 14239 | 0.000 |
Why?
|
|
Bellido's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts ![Expand Description](https://uams-triprofiles.uams.edu/profiles/Framework/Images/info.png) Derived automatically based on a person's publications. Keywords from attributed publications are matched to keywords from the MeSH. _
Co-Authors ![Expand Description](https://uams-triprofiles.uams.edu/profiles/Framework/Images/info.png) People in Profiles who have published with this person. _
Similar People ![Expand Description](https://uams-triprofiles.uams.edu/profiles/Framework/Images/info.png) People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|